JG

Jeff Goater

Partner at The Column Group

Greater Boston

Overview

Work Experience

Topo Therapeutics

  • Board Member

    2024 - Current

NT

NILO Therapeutics

  • Board Member

    2024

KT

Kenai Therapeutics

  • Board Member

    2024

TC

The Column Group

  • Partner

    2024

  • Venture Partner

    2021 - 2023

RT

Remix Therapeutics

  • Board Member

    2023

A

AviadoBio

  • Chair

    2023

Stealth Biotech Company

  • Executive Chair

    2022

K

Kallyope

  • Board Member

    2022

AB

Atavistik Bio

  • Board Member

    2021

  • Interim CEO

    2022 - 2023

RT

Ribon Therapeutics

  • Board Member

    2021 - 2024

Education

Investments

Kenai Therapeutics

Series A

Total Funding: $82M

Atavistik Bio

Series A

Total Funding: $100M

Relevant Websites